Boosting the pharmacokinetics of atazanavir with cobicistat

Trial Profile

Boosting the pharmacokinetics of atazanavir with cobicistat

Phase of Trial: Phase I

Latest Information Update: 14 Sep 2009

At a glance

  • Drugs Atazanavir (Primary) ; Cobicistat (Primary) ; Ritonavir
  • Indications HIV infections
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 14 Sep 2009 Results reported at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy.
    • 13 Feb 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top